Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$252,423,729
+$6,686,467 QoQ
Shares Held
10,482,713
+19.8% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#58
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIL Ltd holds $2,310,187,043 across 11 Drug Manufacturers - General names. PFE ranks #3 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,492,612 | $851,889,084 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,523,813 | $375,902,104 | |
| 3 | PFE |
Pfizer Inc
This page
|
10,482,713 | $252,423,729 | |
| 4 | LLY |
ELI LILLY & Co
|
201,889 | $242,151,742 | |
| 5 | ABBV |
AbbVie Inc.
|
677,123 | $170,391,231 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
987,104 | $124,710,718 | |
| 7 | JNJ |
Johnson & Johnson
|
431,712 | $109,641,896 | |
| 8 | MRK |
Merck & Co., Inc.
|
678,957 | $87,245,974 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,423,729 | 10,482,713 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $245,737,262 | 8,751,327 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $230,353,684 | 9,251,152 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $302,802,179 | 11,883,916 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $224,753,692 | 9,272,017 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $199,381,784 | 7,868,263 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $180,099,223 | 6,788,512 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $152,679,076 | 5,275,711 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $217,987,731 | 7,790,841 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $258,281,682 | 9,307,448 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $218,300,693 | 7,582,518 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $127,635,605 | 3,847,923 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $114,360,059 | 3,117,777 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,226,463 | 201,629 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $9,196,913 | 179,487 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,158,479 | 163,585 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $9,721,046 | 185,410 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,570,605 | 204,184 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,803,066 | 250,687 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $90,690,326 | 2,108,587 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $169,769,329 | 4,335,274 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $169,582,992 | 4,680,734 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $260,817,401 | 7,085,504 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $483,072,264 | 13,162,745 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $543,422,601 | 16,618,411 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $488,314,301 | 14,960,630 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||